Hu CP - Search Results

1

Dimethyl fumarate is repurposed to ameliorate aortic aneurysm and dissection in mice.

Wang X, Kuang J, Li XT, Hu X, Liu YH, Hu CP, Wang M, Wang Q, Zhang Z. Wang X, et al. Among authors: hu cp. Eur J Pharmacol. 2025 Feb 5;988:177215. doi: 10.1016/j.ejphar.2024.177215. Epub 2024 Dec 18. Eur J Pharmacol. 2025. PMID: 39706468

2

Deficiency of endothelial TRPV4 cation channels ameliorates experimental abdominal aortic aneurysm.

Qian SH, Liu S, Wang M, Wang Q, Hu CP, Huang JH, Zhang Z. Qian SH, et al. Among authors: hu cp. Eur J Pharmacol. 2025 Jan 5;986:177150. doi: 10.1016/j.ejphar.2024.177150. Epub 2024 Nov 20. Eur J Pharmacol. 2025. PMID: 39577553

3

Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes.

Guo Y, Zhang L, Li F, Hu CP, Zhang Z. Guo Y, et al. Among authors: hu cp. Eur J Pharmacol. 2016 Apr 5;776:26-33. doi: 10.1016/j.ejphar.2016.02.052. Epub 2016 Feb 24. Eur J Pharmacol. 2016. PMID: 26921129

4

Corrigendum to "Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes" [Eur. J. Pharmacol. 776 (2016) 26-33].

Guo Y, Zhang L, Li F, Hu CP, Zhang Z. Guo Y, et al. Among authors: hu cp. Eur J Pharmacol. 2016 Jul 5;782:120. doi: 10.1016/j.ejphar.2016.05.002. Eur J Pharmacol. 2016. PMID: 27180043 No abstract available.

5

MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases.

Zou XZ, Liu T, Gong ZC, Hu CP, Zhang Z. Zou XZ, et al. Among authors: hu cp. Eur J Pharmacol. 2017 Feb 5;796:190-206. doi: 10.1016/j.ejphar.2016.12.003. Epub 2016 Dec 2. Eur J Pharmacol. 2017. PMID: 27916556 Review.

6

Epigallocatechin-3-gallate ameliorates hypoxia-induced pulmonary vascular remodeling by promoting mitofusin-2-mediated mitochondrial fusion.

Zhu TT, Zhang WF, Luo P, He F, Ge XY, Zhang Z, Hu CP. Zhu TT, et al. Among authors: hu cp. Eur J Pharmacol. 2017 Aug 15;809:42-51. doi: 10.1016/j.ejphar.2017.05.003. Epub 2017 May 3. Eur J Pharmacol. 2017. PMID: 28478070

7

Aspirin ameliorates pulmonary vascular remodeling in pulmonary hypertension by dampening endothelial-to-mesenchymal transition.

Huang N, Zhu TT, Liu T, Ge XY, Wang D, Liu H, Zhu GX, Zhang Z, Hu CP. Huang N, et al. Among authors: hu cp. Eur J Pharmacol. 2021 Oct 5;908:174307. doi: 10.1016/j.ejphar.2021.174307. Epub 2021 Jul 8. Eur J Pharmacol. 2021. PMID: 34245748

8

miR-100 suppresses mTOR signaling in hypoxia-induced pulmonary hypertension in rats.

Wang AP, Li XH, Gong SX, Li WQ, Hu CP, Zhang Z, Li YJ. Wang AP, et al. Among authors: hu cp. Eur J Pharmacol. 2015 Oct 15;765:565-73. doi: 10.1016/j.ejphar.2015.09.031. Epub 2015 Sep 25. Eur J Pharmacol. 2015. PMID: 26409044

9

LOX-1 mediated phenotypic switching of pulmonary arterial smooth muscle cells contributes to hypoxic pulmonary hypertension.

Zhang W, Zhu T, Wu W, Ge X, Xiong X, Zhang Z, Hu C. Zhang W, et al. Eur J Pharmacol. 2018 Jan 5;818:84-95. doi: 10.1016/j.ejphar.2017.10.037. Epub 2017 Oct 22. Eur J Pharmacol. 2018. PMID: 29069578

10

Down-regulation of miR-204 attenuates endothelial-mesenchymal transition by enhancing autophagy in hypoxia-induced pulmonary hypertension.

Liu T, Zou XZ, Huang N, Ge XY, Yao MZ, Liu H, Zhang Z, Hu CP. Liu T, et al. Among authors: hu cp. Eur J Pharmacol. 2019 Nov 15;863:172673. doi: 10.1016/j.ejphar.2019.172673. Epub 2019 Sep 19. Eur J Pharmacol. 2019. PMID: 31542480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters